Frontier    

Focus      

Professional


   
   
   
  • Series B funding
  • Completed Phase I dose escalations of LB1410 and LB4330
  • Recognized as“Specialized, high-end and innovation-driven SMEs”
  •  2 patents granted in China, 4 patents granted through PCT
2020
   
  
  • Reached collaboration agreement for 1 project
  • Recognized as “Hi-Tech enterprise” by local government
  • Received fund support from “Scientific innovation plan of  action”of Shanghai
  • Received special subsidies for equity financing from government
  • Dr. Luan awarded honorary title of “Leading talent of Minhang”
  • 1 patent granted
    • 2024
    • Series A funding
    • FDA clearance of IND for LB1410
    2021
    2022
    2023
    2016-2018
       
      

    • NMPA clearance of IND for comb (LB1410+LB4330)
    • Initiated Phase I expansion studies of LB1410 and LB4330
    • Recognized as“Hi-Tech enterprise”again
    • CEO was selected as “Scientific and technological leading talent of Wujiang               Economic-Technological Development Zone”
  • Angel round financing
  • Pre-A round financing
  • Licensed out 2 assets
  • Reached collaboration agreement for 3 projects 
  • Received fund support from“Scientific innovation plan of action” of Shanghai
  • CEO was recognized as“Special Expert of Shanghai Municipality“
  • 1 patent granted
    • 2019

    • NMPA clearance of IND for LB1410
    • FDA/NMPA clearance of IND for LB4330
    • Initiated Phase I of LB1410 and LB4330
    • Received 3 fund 
    • 3 patents granted
    • supports from local government
                 History
    当前位置：
    Home ⊙ About us ⊙ History & Honors

                    Honors